ZIOPHARM Oncology, Inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. We are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
http://www.ziopharm.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.2 seconds
ZIOPHARM Oncology, Inc.
Jon Kean
1 Fi●●●● Ave
Buil●●●●g 34
Bo●●on , Massachusetts, 02129
United States
View this contact
ZIOPHARM Oncology, Inc.
Jon Kean
1 Fi●●●● Ave
Buil●●●●g 34
Bo●●on , Massachusetts, 02129
United States
View this contact
ZIOPHARM Oncology, Inc.
Jon Kean
1 Fi●●●● Ave
Buil●●●●g 34
Bo●●on , Massachusetts, 02129
United States
View this contact
BUY YOUR DOMAIN
21
YEARS
6
MONTHS
18
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
12
SSL
EXTERNAL LINKS
86
SITE IP
50.63.103.24
LOAD TIME
0.219 sec
SCORE
6.2
Ziopharm Oncology - Home | ziopharm.com Reviews
https://ziopharm.com
ZIOPHARM Oncology, Inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. We are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
Investors Home - ZIOPHARM Oncology, Inc.
We hope you share our vision of novel cancer and GvHD therapies to help those in need. if you have invested in ziopharm, this section will give you the information and insight you need. Mar 1, 2018. Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update. Feb 13, 2018. Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1. View all press releases ». Mar 1, 2018 at 4:30 PM ET.
ziopharm.com
Pipeline - Ziopharm Oncology
http://www.ziopharm.com/pipeline
Gene and Cell Therapeutics. Gene and Cell Therapeutics. Gene and Cell Therapeutics. Focused on the discovery and development of new cancer therapies. Thanks to a revolutionary technology platform, our pipeline of novel immuno-oncology therapeutics is growing. Using technologies that augment the therapeutic potential of effector cells. Are tailored to the patient and their disease. And are capable of meeting the oncology treatment on a global scale. CAR and Designer Cytokine- controlled T cell. Expression...
About - Ziopharm Oncology
http://www.ziopharm.com/about
Gene and Cell Therapeutics. Gene and Cell Therapeutics. Our goal is simple – to enrich patients’ lives. We’re busy advancing a new generation of cancer and selective auto-immune disease treatments - Find out what we’re up to. NYSE:XON) and the MD Anderson Cancer Center. Platform and advancing programs in multiple stages of development. The Company's preclinical and clinical pipeline focuses on the treatment of hematological and solid tumor malignancies, as well as GvHD, using cellular therapeutics.
Board of Directors - Ziopharm Oncology
http://www.ziopharm.com/about/board-of-directors
Gene and Cell Therapeutics. Gene and Cell Therapeutics. Our board of directors are dedicated to advancing science and medicine while building value for our shareholders. Sir Murray Brennan, M.D. (Lead Director). Emeritus Chairman of Surgery, Memorial Sloan Kettering Cancer Center. James A. Cannon. CHIEF FINANCIAL OFFICER AND VICE CHAIRMAN, BBDO. Senator Wyche Fowler, Jr. FORMER U.S. SENATOR AND AMBASSADOR TO SAUDI ARABIA. Randal J. Kirk. Michael Weiser, M.D., Ph.D. PARTNER, ACTIN BIOMED.
Medical Advisory Board - Ziopharm Oncology
http://www.ziopharm.com/about/medical-advisory-board
Gene and Cell Therapeutics. Gene and Cell Therapeutics. Our medical advisory board includes some of the world’s foremost experts in cancer research and medicine. James Armitage, M.D. Joseph Bertino, M.D. George Demetri, M.D. Lawrence Einhorn, M.D. Alan Houghton, M.D. Alberto Pappo, M.D. John F. Smyth, M.D. Jedd Wolchok, M.D., Ph.D.
Management Team - Ziopharm Oncology
http://www.ziopharm.com/about/management-team
Gene and Cell Therapeutics. Gene and Cell Therapeutics. Our team cares deeply about advancing cancer treatment through the transformative potential of DNA therapy. Laurence J.N. Cooper, M.D., Ph.D. Caesar J. Belbel. Executive Vice President, Chief Operating Officer, Chief Legal Officer and Secretary. Francois Lebel, M.D. Executive Vice President, Research and Development, Chief Medical Officer. Lynn M. Ferrucci. SVP, Human Resources, Facilities and Administration. Kevin G. Lafond.
TOTAL PAGES IN THIS WEBSITE
12
Thorium Digital - Part 2
http://www.thoriumdigital.com/page/2
Energy for your digital movement. We turn your vision. Working closely with you, we provide end-to-end digital services that are based on proven techniques and tailored to your business and technology needs. We have provided our consulting services to clients from startups to Fortune 500 companies, across multiple industry groups. We design and build your applications the right way. We help you connect with your customers. We build the system for you to manage your content. A new digital world. The evolu...
Press Releases - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/releases.cfm
Here is an up-to-date collection of any information given to the press. It’s a big collection, so try not to look at it all in one sitting. Aug 9, 2016. ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities. Aug 4, 2016. First-In-Human Trials using Non-Viral Sleeping Beauty System to Express CD19-Specific CAR in T cells Published in Journal of Clinical Investigation. Aug 2, 2016. BOSTON, Aug. 02, 2016 (GLOBE NEWSWIRE) - ZIOPHARM Oncology, Inc. (Nasdaq:ZIO...BOSTO...
Email Alerts Subscription - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/profile.cfm
There's plenty of comprehensive tools in this section. register to get the full experience. you can download, subscribe, and everything in between. Step 1 of 3: Select Options. You may automatically receive ZIOPHARM Oncology, Inc. financial information by email. Please enter your preferences for email notifications below and click Continue to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Quarterly and Annual Reports.
SEC Filings - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/sec.cfm
This section is a comprehensive database of our sec filings. All Filings (excluding Section 16). Aug 9, 2016. Aug 9, 2016. Aug 2, 2016. Statement, of changes of beneficial ownership. Jul 20, 2016. Jul 19, 2016. Jul 15, 2016. Jul 14, 2016. Jul 7, 2016. Small company offering and sale of securities without registration. Jul 6, 2016. Amended general statement of beneficial ownership. Jul 6, 2016. Statement, of changes of beneficial ownership. 10 results per page. 25 results per page. 50 results per page.
Stock Information - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/stockquote.cfm
Our investors are important to us. keep track of our stock price here. 009 ( 1.741%). 4:00 PM ET on Aug 26, 2016. Sign up for email alerts.
17th Annual BIO CEO & Investor Conference - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/eventdetail.cfm?EventID=156128
17th Annual BIO CEO and Investor Conference. We like to stay active and engage with the community to discuss our research. Feel free to listen or attend our presentations. 17th Annual BIO CEO and Investor Conference. Feb 10, 2015.
Events & Presentations - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/events.cfm
We like to stay active and engage with the community to discuss our research. Feel free to listen or attend our presentations. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Aug 9, 2016. Ziopharm Second Quarter 2016 Financial Results Conference Call. Jun 9, 2016. Jefferies 2016 Healthcare Conference. Feb 9, 2016. 18th Annual Bio Ceo and Investor Conference. Jan 13, 2016. 34th Annual J.P. Morgan Healthcare Conference. Dec 16, 2015. Oct 14, 2015.
Analyst Coverage - ZIOPHARM Oncology, Inc.
http://ir.ziopharm.com/analysts.cfm
Our investors are important to us. keep track of our stock price here. ZIOPHARM Oncology, Inc. is covered by the following analysts. JP Morgan Securities Inc. Raymond James and Associates.
ZIOP: Message Board for ZIOPHARM Oncology, Inc. - InvestorVillage
http://beta.investorvillage.com/smbd.asp?mb=16353
389 members / 819 guests. ZIOPHARM Oncology, Inc. Create your FREE account now. Up to 23 characters, no spaces or apostrophes allowed. You must enter a valid email address to receive account confirmation instructions, otherwise you will be unable to post. I have read and agree to the InvestorVillage. If you have trouble registering, please call our customer support at 1-888-222-7309. 101 Reasons to Own Ziopharm. The Cancerful Foundation - Donation Page. 2015 Year End Presentation. ZIOP / Message Board.
TOTAL LINKS TO THIS WEBSITE
86
ziopera.it
Welcome to the home of ziopera.it. Our domain has just been registered,we will be online very soon indeed. Date Created: Mon Nov 9 17:32:22 2009.
Zio Pesce
Novità e Degustazioni. Menù speciali per più di 10 persone. AVVERTIAMO LA GENTILE CLIENTELA CHE ZIO PESCE IN VIA CICCO SIMONETTA 8. SARA' CHIUSO PER FERIE DAL 09 AGOSTO AL 23 AGOSTO. BUONE FERIE! ZIO PESCE IN VIA MAFFEI 12 SARA' APERTO TUTTO IL MESE DI AGOSTO. Devi fare un regalo? Scopri la SevenGiftCard. clicca qui. Zio Pesce è un marchio Seven Group. 2005 Navarca - Studio Bluelettrico.
Zio Pesce - Restaurant & Officina di Mare - Lecce - Salento - Zio Pesce
Il sito di Zio Pesce utilizza cookies per migliorare l'esperienza di navigazione degli utenti. Chiudendo questo banner si acconsente all’uso dei cookies. Restaurant / Officina di Mare a Lecce - Salento. Dal mare salentino la genuinità e la freschezza del nostro pescato. Zio Pesce - Officina di Mare. Il Bacaro - Restaurant Steak House. Zio Pesce - Restaurant / Officina di Mare a Lecce in Via Gobetti, 19 - t. 0832316857. Download Free Premium Joomla Templates FREE High-quality Joomla!
Ziopharm Oncology - Home
Gene and Cell Therapeutics. Gene and Cell Therapeutics. We’re advancing a new generation of cancer treatments. The immune system is a powerful tool. By redirecting the immune cells to a cancer target. And using new technologies to control them. We can create safer, more effective therapies to restore health and prolong life for many.
zio phella's band | the official website
Zio phella's band. Questo slideshow richiede JavaScript. Il gruppo nasce nell’Aprile del 2012 dall’incontro di Max, Marco, Andrea, Gabriele e Luca, provenienti da esperienze musicali pluriennali di varia natura (pop, rock, metal, blues), già attivi individualmente anche in altri progetti musicali ( Fuorilogo, Quelli che il Blasco, Luca Lastilla, etc). I loro variegati background rendono la miscela musicale degli Zio Phella’s dinamica, sfaccettata e coinvolgente. Blog su WordPress.com.
ZioPhoto.com - Washington DC, Maryland, Virgina Professional Photography Services
